Literature DB >> 12964575

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Guy De Backer1, Ettore Ambrosioni, Knut Borch-Johnsen, Carlos Brotons, Renata Cifkova, Jean Dallongeville, Shah Ebrahim, Ole Faergeman, Ian Graham, Giuseppe Mancia, Volkert Manger Cats, Kristina Orth-Gomér, Joep Perk, Kalevi Pyörälä, José L Rodicio, Susana Sans, Vedat Sansoy, Udo Sechtem, Sigmund Silber, Troels Thomsen, David Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12964575     DOI： 10.1016/s0195-668x(03)00347-6

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  310 in total

1.  Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.

Authors:  Mandip S Dhamoon; Mitchell S V Elkind
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

Review 2.  [Evaluation of cardiovascular risk. What table to use?].

Authors:  A Maiques Galán
Journal:  Aten Primaria       Date:  2003-12       Impact factor: 1.137

3.  European society issues guidelines on cardiovascular disease.

Authors:  Susan Mayor
Journal:  BMJ       Date:  2003-09-06

4.  [Secondary prevention of cardiovascular diseases].

Authors:  C A Schneider; E Erdmann
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

Review 5.  Management of dyslipidaemia.

Authors:  Gilbert R Thompson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

6.  [Cardiovascular prevention and rehabilitation].

Authors:  C von Schacky
Journal:  Internist (Berl)       Date:  2003-12-20       Impact factor: 0.743

7.  Intensified Lipid-Lowering Therapy in Coronary Heart Disease: Is the Concept of "the Lower the Better" Evidence Based?

Authors:  Erland Erdmann
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-02

8.  Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.

Authors:  Simone R B M Eussen; Johanna M Geleijnse; Erik J Giltay; Cathy J M Rompelberg; Olaf H Klungel; Daan Kromhout
Journal:  Eur Heart J       Date:  2012-02-01       Impact factor: 29.983

9.  Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice.

Authors:  Q Wan; M F Harris; U W Jayasinghe; J Flack; A Georgiou; D L Penn; J R Burns
Journal:  Qual Saf Health Care       Date:  2006-04

Review 10.  Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.